HOME > NEWS > Industry Information

Byte beat, incoming medical device!

Categories:Industry Information      Release time:2020-12-27

Byte beating medical chess

On December 24, according to Sohu technology, latepost later and other news, AI Lab's teams in Beijing, Shanghai and the United States are recruiting talents in the field of AI drug.

Tiktok AI Lab was founded in 2016, focusing on the development of byte beating platform, and the built-in effects of App, such as jitter, volcano, etc., are from the Department.

Meanwhile, byte beat has established an aurora department specifically responsible for big health business, led by Wu Haifeng, former vice president of Baidu, to report to Zhang Yiming, Global CEO of byte beat.

Tianyancha information shows that in December this year, Xiaohe Health Technology (Beijing) Co., Ltd., a subsidiary of byte beat, took a wholly-owned stake in 1024 Technology (Hainan) Co., Ltd.

It is understood that after leaving Baidu, Wu Haifeng and former Baidu executive director Sun Wenyu jointly founded the internet medical service company 1024. Its business scope includes medical equipment leasing, medical and medical consulting services, health consulting, medical services, etc.

At present, almost all of the main products of byte Aurora department come from 1024, including offline diagnosis and treatment institution pinecone clinic, doctor's Internet practice platform Xiaohe doctor app, medical service and content platform Xiaohe app, etc.

In fact, the first step in the cross Bureau medical industry was to complete the wholly-owned acquisition of the encyclopedia famous medical network, a medical popular science knowledge platform, in August this year.

Several Internet giants have entered the device industry

Compared with other Internet or technology giants, the pace of entering the medical industry may be slightly slow. Before that, many Internet or technology companies such as Tencent, Alibaba and Baidu have begun to layout the medical industry, and many new actions have been taken recently.

On November 5, cypress blue device inquired the website of the State Food and Drug Administration and found that Tencent successfully obtained the class II medical device registration certificate through Tencent medical health (Shenzhen) Co., Ltd. The certified product is medical image storage and transmission system software, which is expected to be used for medical image management, reception, display, storage, output and processing for clinical diagnosis and treatment.

In October this year, according to Tencent technology news, Baitu Shengke, a life science platform company, was officially established. Robin Li, founder, chairman and CEO of Baidu, is determined to take the lead and become the chairman of the new company in person. BV Baidu venture capital CEO Liu Wei is co founder of CEO.

According to the information on the official website, Baitu biotechnology plans to invest more than 10 billion yuan to build an independent and controllable biological computing platform to solve life science problems by using AI capabilities such as cutting-edge algorithms, intelligent sensors, intelligent chips and micro nano robots. Use technology + capital to accelerate the research and development of precision life science products such as drug design, target discovery, precision diagnosis and digital medicine.

In February this year, according to the global network, the business scope of Shenzhen Lenovo understanding Communication Co., Ltd., a wholly-owned subsidiary of Lenovo Group, was changed, and the new business was "wholesale and sales of class II medical devices". Its legal representative is Wang Shuai, vice president of Lenovo Group, and the president is Yang Yuanqing, President and CEO of Lenovo Group.

In November 2019, according to qixinbao, Shanghai Sankuai Technology Co., Ltd., invested by meituan, invested in Shenzhen Baishou Health Information Technology Co., Ltd. from the perspective of the company's business scope, including the sales of class II and class III medical devices.

As can be seen from the equity penetration chart of the company, Wang Xing, CEO of meituan, holds 95%, and Mu Rong, co-founder and CTO of meituan, holds 5%. At present, he is responsible for the financial services and corporate affairs of meituan's comments.

Online distribution may become an industry trend

In addition to Baidu, Tencent and other giants, the listing of JD health has become a hot topic in the industry recently. Just this month, JD health was officially listed on the main board of the Hong Kong stock exchange.

According to the prospectus of JD health, according to frost Sullivan's report, JD health is China's largest online medical and health platform and the largest online retail pharmacy in terms of revenue in 2019. As of June 30, 2020, more than 150 million users had used JD health to purchase medicine and health products or medical and health services.

According to the frost Sullivan report, 25.8% of the total retail sales of consumer goods in 2019 were distributed online. In contrast, in 2019, only 7.6% of out of hospital dr

ug sales were distributed online, and 16.8% of medical devices in medical device retail were distributed online.

The standardized nature of medical and health products and the repeated purchase demand related to chronic diseases are expected to rapidly expand the online penetration of these medical and health products.

It is estimated that by 2030, 27.5% of drugs will be distributed online through out of hospital drug sales channels, and 40.9% of medical devices will be distributed online through medical device retail channels.

At present, JD health has cooperated with many well-known machinery enterprises. For example, in July this year, JD health signed a cooperation agreement with Siemens Medical, and the two sides will improve the service capacity of non-public medical institutions in the field of medical devices and large-scale medical equipment; In December 2019, JD health and Lexin medical reached a cooperation, and the two companies jointly released a medical grade ECG watch.

According to AI media consulting data, the total sales volume of Chinese pharmaceutical e-commerce directly reported enterprises has increased rapidly since 2015. In 2019, the total sales volume of Chinese pharmaceutical e-commerce directly reported enterprises exceeded 100 billion yuan. The sales of China's pharmaceutical e-commerce direct reporting enterprises will maintain a compound annual growth rate of about 17%, which is expected to be close to 140 billion yuan in 2021.

In fact, the impact of the Internet on the medical device industry is not confined to the circulation of the electricity supplier. The analysis of China intelligence network, "Internet plus medical" helps the development of the industry, and the Internet is closely integrated with the equipment industry. The information level of the whole industry will be generally promoted, and the information of the products can be traced back, and the whole process of the production and circulation of medical devices should be supervised by means of information.

With the advent of 5g era, the interconnection of all things will greatly improve the wide application of medical devices. At present, the information traceability mechanism, system and coding in the field of medical devices are not perfect and need to be further improved.

Leave message
  • No.133 ,Lengshui Road,Jinpan Development Zone,Jinhua City, Zhejiang Province, China
  • 0579-82235599 / 82208277
  • 0579-82235397
Quick Entry
Copyright © Zhejiang Xinke Medical Technology Co., Ltd.      浙ICP备09037803号